DAR Analysis of Antibody–Drug Conjugates
In this application note, an antibody–drug conjugate (ADC) was analyzed using a TSKgel® Butyl-NPR column, the least hydrophobic of the TSKgel HIC columns. Both unconjugated and drug conjugated Trastuzumab samples were successfully separated with baseline resolution. The baseline resolution enabled an easy integration and quantification of different drug pay loads in ADC characterization.
Tosoh Bioscience GmbH
In this application note, an antibody–drug conjugate (ADC) was analyzed using a TSKgel® Butyl-NPR column, the least hydrophobic of the TSKgel HIC columns. Both unconjugated and drug conjugated Trastuzumab samples were successfully separated with baseline resolution. The baseline resolution enabled an easy integration and quantification of different drug pay loads in ADC characterization.
In antibody–drug conjugates (ADCs) a cytotoxic drug is chemically bonded to an antibody (IgG). Because antibodies have numerous binding sites for a low-molecular-weight drug, heterogeneity arises with respect to the number of bonded drug molecules and the binding sites. Since low molecular drugs are more hydrophobic than monoclonal antibodies, differences in hydrophobicity arise when the numbers of bonded drug molecules differ. This property can be utilized to determine the drug-to-antibody ratio (DAR) by hydrophobic interaction chromatography (HIC).
Material and Methods
Column: TSKgel Butyl-NPR, 4.6 mm × 10 cm L
Mobile phases: A) 25 mmol/L phosphate buffer (pH 7.0) including 1.5 mol/L ammonium sulphate
B) 25 mmol/L phosphate bufffer (pH 7.0)/2-propanol = 8/2
Gradient: 0100% B (20 min)
Flow rate: 0.5 mL/min
Detection: UV @ 280 nm
Injection volume: 10 μL
Sample: Trastuzumab (0.24 mg/mL), ADC (Trastuzumab-vcMMAE, 2.2 mg/mL)
Results
An ADC (Trastuzumab-vcMMAE) in which an antineoplastic drug (monomethyl auristatin E, MMAE) is bonded via a linker to Trastuzumab was analyzed by hydrophobic interaction chromatography using a TSKgel Butyl-NPR column. By optimizing the organic solvent concentration in solvent B, peaks exhibiting different DARs (DAR = 0 to 8) could be separated well. To confirm the DAR, each peak was fractionated and attributed by liquid chromatography tandem mass spectrometry (LC–MS/MS) (data not shown).
Figure 1: HIC analysis of unconjugated Trastuzumab and drug conjugated Trastuzumab.
Both samples, unconjugated monoclonal antibody (Trastuzumab) and drug conjugated Trastuzumab (Trastuzumab-vcMMAE), were analyzed with a 4.6 mm × 10 cm, 2.5-μm TSKgel Butyl-NPR column. The unconjugated Trastuzumab was eluted as a major single peak (Figure 1, upper panel). The chromatogram of the drug conjugated Trastuzumab exhibited well resolved peaks with different retention times than that of the unconjugated antibody (Figure 1, lower panel). These well resolved peaks represent different drug-to-antibody ratios ranging from 0 to 8. The lower drug-loaded, less hydrophobic peaks elute first and the higher drug-loaded peaks elute later.
Conclusion
TSKgel Butyl-NPR, the least hydrophobic of the TSKgel HIC columns, is the best choice for efficient separation of antibody–drug conjugates. The 2.5-µm non-porous particles can be used with both conventional high pressure liquid chromatography (HPLC) and ultrahigh-pressure LC (UHPLC) systems.
Tosoh Bioscience GmbH
Im Leuschnerpark 4 64347 Griesheim, Darmstadt, Germany
Tel: +49 6155 7043700 Fax: +49 6155 8357900
E-mail: info.tbg@tosoh.com
Website: www.tosohbioscience.de
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ion used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
